A NON-RANDOMIZED PROSPECTIVE CLINICAL TRIAL COMPARING THE NONINFERIORITY OF SALPINGECTOMY TO SALPINGO-OOPHORECTOMY TOREDUCE THE RISK OF OVARIAN CANCER AMONG BRCA1 CARRIERS SOROCk
Comparing Surgeries to Reduce the Risk of Ovarian Cancer in Women with BRCA1 Mutations
Sponsor: NA
Enrolling: Female Patients Only
IRB Number: AAAT5400
U.S. Govt. ID: NCT04251052
Contact: Reena Vattakalam: 212-342-6895 / rmv2110@cumc.columbia.edu
Additional Study Information: The main purpose of this study is to determine if two surgical procedures, the usual approach of removing the fallopian tubes and ovaries and the other approach of removing the fallopian tubes at this time with the plan to remove the ovaries at a later time, are no different for ovarian cancer risk reduction in women with BRCA1 mutations who have completed childbearing. In this study, the removal of fallopian tubes will be compared to the removal of fallopian tubes and ovaries. The study will also examine what factors go into deciding which surgery to have and symptoms after surgery caused by lack of estrogen due to ovary removal.
Investigator
Jason Wright, MD
Do You Qualify?
Do you have BRCA1 mutations? Yes No
Do you have at least one intact ovary and fallopian tube? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Reena Vattakalam
rmv2110@cumc.columbia.edu
212-342-6895